Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...

Weight loss drugs help manage blood sugar levels by mimicking two important hormones GLP-1 (glucagon-like peptide-1) and GIP ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

A mass rollout of weight loss injections begins across the NHS on Monday, with GPs able to prescribe Mounjaro for the first ...

Thousands of patients in England will be able to access weight loss jabs via their GP from Monday as they are allowed to ...

As the NHS rolls out weight loss drugs like Mounjaro more widely, we’re asking whether they should be available to all who ...

With the weight-loss blockbuster drug Wegovy, now in India, renowned endocrinologist and diabetologist Dr. Ambrish Mithal ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...